MedTrace Logo

Cardiovascular Risk in Patients With Takayasu Arteritis: A Nationwide Population-Based Cohort Study

NCT07686991 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8275

Last updated 2026-07-07

No results posted yet for this study

Summary

This nationwide observational cohort study compares the risk of major adverse cardiovascular events (MACE) and territory-specific arterial complications between patients with incident Takayasu arteritis and matched general-population controls, and identifies determinants of MACE within the Takayasu arteritis population, including cumulative glucocorticoid exposure, using the French National Health Data System (SNDS).

Conditions

Sponsors & Collaborators

  • Groupe français d'étude des Maladies Inflammatoires de loeil

    lead OTHER

Principal Investigators

  • Alexis Guedon · APHP - HOPITAL SAINT ANTOINE

Eligibility

Min Age
15 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-01
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07686991 on ClinicalTrials.gov